ASX:DRUG

BetaShares Global Healthcare ETF - Currency Hedged (DRUG) Stock Price, News & Analysis

→ Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad)

Free DRUG Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Ad InvestorPlace

Read this before you buy AI stocks

BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts.

Starting today, you could siphon a new stream of income from this $3 billion pool of cash.

About BetaShares Global Healthcare ETF - Currency Hedged

Ad InvestorPlace

Read this before you buy AI stocks

Starting today, you could siphon a new stream of income from this $3 billion pool of cash.

DRUG Stock News Headlines

May 15, 2024 | fool.com

These Are Billionaires’ Favorite Healthcare Stocks

April 22, 2024 | reuters.com

Hedge fund assets reach $4.3 trillion in Q1, says HFR

April 8, 2024 | finance.yahoo.com

BetaShares Global Gold Miners ETF - Currency Hedged (MNRS.AX)

April 1, 2024 | marketwatch.com

Fractyl Health Shares Rise 40% After FDA Approval of IDE for Revita

See More Headlines

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Sub-Industry: N/A
Current Symbol: ASX:DRUG
CUSIP: N/A
CIK: N/A
Web: N/A
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Competitors

View All Competitors

This page (ASX:DRUG) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

BetaShares Global Healthcare ETF - Currency Hedged (DRUG) Stock Price, News & Analysis

About BetaShares Global Healthcare ETF - Currency Hedged

DRUG Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Competitors

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info